CXCR4 PET/CT imaging for related conditions
Part of Cancer clinical trials.
This trial uses a special imaging scan (CXCR4 PET/CT) to help diagnose or evaluate certain diseases linked to a protein called CXCR4. It may offer more detailed information than standard scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are suspected to have a lymphoproliferative or other CXCR4-related disease that has not been treated yet.
- You have had a standard FDG PET/CT scan within the last two weeks.
- You are willing and able to sign a consent form.
- You are not pregnant or breastfeeding.
- You have no known allergy to the imaging agent Pentixafor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of imaging scan (PD-L1 PET/CT) that may help doctors better see and understand cancers. The scan uses a special tracer to highlight cancer cells in your body, which could help guide treatment decisions.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This early-stage trial tests a new type of imaging scan (called PET) that uses a special tracer to help doctors see tumors better. The scan targets a protein called CAIX that appears on many cancer cells, which may help with accurate diagnosis and staging.
This trial looks at an imaging scan called CXCR4-targeted PET/CT to help doctors see certain blood cancers. You may be helped by getting clearer information about where cancer is in your body, and the results may guide future care.
This early study tests a new PET scan tracer (a radioactive imaging agent) that may light up a cell marker called CXCR4 in certain blood and solid tumor cancers. It may help doctors see where cancers are and how much CXCR4 they have, which could guide future treatments.
This study tests a new imaging method called CXCR4 PET/CT that may help doctors better see and understand lymphomas (a type of blood cancer). It is for people who are newly diagnosed or suspected of having lymphoma and have already had a standard PET/CT.
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.